Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women
- PMID: 26134388
- PMCID: PMC4531470
- DOI: 10.1017/S0007114515001786
Dietary modulation of the gut microbiota--a randomised controlled trial in obese postmenopausal women
Abstract
The gut microbiota has been implicated in obesity and its progression towards metabolic disease. Dietary interventions that target the gut microbiota have been suggested to improve metabolic health. The aim of the present study was to investigate the effect of interventions with Lactobacillus paracasei F19 or flaxseed mucilage on the gut microbiota and metabolic risk markers in obesity. A total of fifty-eight obese postmenopausal women were randomised to a single-blinded, parallel-group intervention of 6-week duration, with a daily intake of either L. paracasei F19 (9.4 × 1010 colony-forming units), flaxseed mucilage (10 g) or placebo. Quantitative metagenomic analysis of faecal DNA was performed to identify the changes in the gut microbiota. Diet-induced changes in metabolic markers were explored using adjusted linear regression models. The intake of flaxseed mucilage over 6 weeks led to a reduction in serum C-peptide and insulin release during an oral glucose tolerance test (P< 0.05) and improved insulin sensitivity measured by Matsuda index (P< 0.05). Comparison of gut microbiota composition at baseline and after 6 weeks of intervention with flaxseed mucilage showed alterations in abundance of thirty-three metagenomic species (P< 0.01), including decreased relative abundance of eight Faecalibacterium species. These changes in the microbiota could not explain the effect of flaxseed mucilage on insulin sensitivity. The intake of L. paracasei F19 did not modulate metabolic markers compared with placebo. In conclusion, flaxseed mucilage improves insulin sensitivity and alters the gut microbiota; however, the improvement in insulin sensitivity was not mediated by the observed changes in relative abundance of bacterial species.
Keywords: Flaxseed mucilage; Gut microbiota; Metagenomics; Obesity-related disease; Probiotics.
Figures
Similar articles
-
Probiotics modulate gut microbiota and improve insulin sensitivity in DIO mice.J Nutr Biochem. 2017 Dec;50:16-25. doi: 10.1016/j.jnutbio.2017.08.006. Epub 2017 Aug 26. J Nutr Biochem. 2017. PMID: 28968517
-
A gut microbiota-targeted dietary intervention for amelioration of chronic inflammation underlying metabolic syndrome.FEMS Microbiol Ecol. 2014 Feb;87(2):357-67. doi: 10.1111/1574-6941.12228. Epub 2013 Oct 21. FEMS Microbiol Ecol. 2014. PMID: 24117923 Free PMC article. Clinical Trial.
-
GUT MICROBIOTA, PREBIOTICS, PROBIOTICS, AND SYNBIOTICS IN MANAGEMENT OF OBESITY AND PREDIABETES: REVIEW OF RANDOMIZED CONTROLLED TRIALS.Endocr Pract. 2016 Oct;22(10):1224-1234. doi: 10.4158/EP151157.RA. Epub 2016 Jul 13. Endocr Pract. 2016. PMID: 27409822 Review.
-
Supplementation of Lactobacillus curvatus HY7601 and Lactobacillus plantarum KY1032 in diet-induced obese mice is associated with gut microbial changes and reduction in obesity.PLoS One. 2013;8(3):e59470. doi: 10.1371/journal.pone.0059470. Epub 2013 Mar 21. PLoS One. 2013. PMID: 23555678 Free PMC article.
-
Gut microbiota interactions with obesity, insulin resistance and type 2 diabetes: did gut microbiote co-evolve with insulin resistance?Curr Opin Clin Nutr Metab Care. 2011 Sep;14(5):483-90. doi: 10.1097/MCO.0b013e328348c06d. Curr Opin Clin Nutr Metab Care. 2011. PMID: 21681087 Review.
Cited by 25 articles
-
Probiotic Strains and Intervention Total Doses for Modulating Obesity-Related Microbiota Dysbiosis: A Systematic Review and Meta-analysis.Nutrients. 2020 Jun 29;12(7):1921. doi: 10.3390/nu12071921. Nutrients. 2020. PMID: 32610476 Free PMC article. Review.
-
The Effect of Probiotics and Synbiotics on Risk Factors Associated with Cardiometabolic Diseases in Healthy People-A Systematic Review and Meta-Analysis with Meta-Regression of Randomized Controlled Trials.J Clin Med. 2020 Jun 8;9(6):1788. doi: 10.3390/jcm9061788. J Clin Med. 2020. PMID: 32521799 Free PMC article. Review.
-
Fermented Dairy Products, Probiotic Supplementation, and Cardiometabolic Diseases: A Systematic Review and Meta-analysis.Adv Nutr. 2020 Jul 1;11(4):834-863. doi: 10.1093/advances/nmaa030. Adv Nutr. 2020. PMID: 32277831
-
An Updated Overview on Nanonutraceuticals: Focus on Nanoprebiotics and Nanoprobiotics.Int J Mol Sci. 2020 Mar 26;21(7):2285. doi: 10.3390/ijms21072285. Int J Mol Sci. 2020. PMID: 32225036 Free PMC article. Review.
-
Role of gut microbiota in type 2 diabetes pathophysiology.EBioMedicine. 2020 Jan;51:102590. doi: 10.1016/j.ebiom.2019.11.051. Epub 2020 Jan 3. EBioMedicine. 2020. PMID: 31901868 Free PMC article. Review.
References
-
- World Health Organization (2012) World Health Statistics. Geneva: WHO.
-
- Qin J, Li Y, Cai Z, et al. (2012) A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature 490, 55–60. - PubMed
-
- Cotillard A, Kennedy SP, Kong LC, et al. (2013) Dietary intervention impact on gut microbial gene richness. Nature 500, 585–588. - PubMed
-
- Le Chatelier E, Nielsen T, Qin J, et al. (2013) Richness of human gut microbiome correlates with metabolic markers. Nature 500, 541–546. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
-
Full Text Sources
-
Other Literature Sources
-
Medical